ICAM1 and non-small cell lung carcinoma: Moreover, Kaplan-Meier analysis revealed significant association of high ICAM-1 expression with poor progression-free survival (FP) and overall survival (OS) of NSCLC patient cohorts in databases including the Gene Expression Omnibus (GEO), European Genome-phenome Archive (EGA) and TCGA (Fig. 1D) [30].